Page 258«..1020..257258259260..270280..»

Ventricular structure and function in hypertensive patients | IJGM – Dove Medical Press

Posted: Published on May 7th, 2022

Introduction Hypertension is a major risk factor of cardiovascular morbidity and mortality in China and worldwide.13 According to the China Hypertension Survey,4 the number of adults with hypertension is nearly 245 million. Continue reading

Posted in Ventricular Remodeling | Comments Off on Ventricular structure and function in hypertensive patients | IJGM – Dove Medical Press

4 promising heart failure therapies interventional cardiologists should keep an eye on – Cardiovascular Business

Posted: Published on May 7th, 2022

Medical researchers have stayed busy in recent years working to develop new interventional heart failure treatments that offer more relief than guideline-directed medical therapy (GDMT) without requiring a left ventricular assist device (LVAD) or heart transplant. The interventional cardiologists at Cleveland Clinics Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute, for instance, are involved in multiple clinical trials exploring these promising therapies Continue reading

Posted in Ventricular Remodeling | Comments Off on 4 promising heart failure therapies interventional cardiologists should keep an eye on – Cardiovascular Business

LEXEO Therapeutics Announces Data Presentations at the 25th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting – Yahoo Finance

Posted: Published on May 7th, 2022

NEW YORK, May 03, 2022 (GLOBE NEWSWIRE) -- LEXEO Therapeutics (LEXEO), a clinical-stage gene therapy company advancing a pipeline of adeno-associated virus (AAV)-based gene therapy candidates for genetically defined cardiovascular and central nervous system (CNS) diseases, today announced that new preclinical data supporting its plakophilin-2 (PKP2) arrhythmogenic right ventricular cardiomyopathy (ARVC) program, Friedreichs ataxia (FA) cardiomyopathy program, and second-generation APOE4 Alzheimers disease program will be presented at the 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), which is being held live in Washington, D.C. and virtually from May 16-19, 2022. Continue reading

Posted in Ventricular Remodeling | Comments Off on LEXEO Therapeutics Announces Data Presentations at the 25th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting – Yahoo Finance

4basebio and Italian partner developing new weapon to fight heart disease – Business Weekly

Posted: Published on May 7th, 2022

Cambridges 4basebio Plc and Italian company Heqet Therapeutics have formed a joint venture to develop a non-viral vector therapy for cardiac regeneration. 4basebio is a life sciences group focused on exploiting IP in the field of cell and gene therapies and DNA and mRNA vaccines; HeqetvTherapeutics isa Kings College London biotech spin-out developing novel RNAi therapeutics to reverse the damage created by ischemic heart disease. The new JDA is focused on the development of a non-viral vector, incorporating a proprietary Heqet payload for cardiomyocyte regeneration and treatment of myocardial infarction more broadly. Continue reading

Posted in Cardiac Regeneration | Comments Off on 4basebio and Italian partner developing new weapon to fight heart disease – Business Weekly

T4 Shows Potential as a Combination Treatment for Diabetes-Induced Complications of the Cornea – PR Newswire

Posted: Published on May 7th, 2022

ROCKVILLE, Md., May 4, 2022 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting that researchers have demonstrated the therapeutic efficacy of Thymosin Beta 4 (T4) as a combination treatment against hyperglycemia (diabetic)-induced changes in human corneal epithelial cells. "Our study elucidates for the first time that a T4 and vasoactive intestinal peptide (VIP) combo treatment plays a crucial role in regulating the tight junction stability and cytoskeleton rearrangement [of the cornea], which are closely related to barrier integrity Continue reading

Posted in Cardiac Regeneration | Comments Off on T4 Shows Potential as a Combination Treatment for Diabetes-Induced Complications of the Cornea – PR Newswire

Tenaya Therapeutics to Present Preclinical Data on Gene Therapy Programs and Platform Capabilities at the American Society of Gene and Cell Therapy…

Posted: Published on May 7th, 2022

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tenaya Therapeutics, Inc. Continue reading

Posted in Cardiac Regeneration | Comments Off on Tenaya Therapeutics to Present Preclinical Data on Gene Therapy Programs and Platform Capabilities at the American Society of Gene and Cell Therapy…

Plug-and-Play Human Organ-on-a-Chip Can Be Customized to the Patient – SciTechDaily

Posted: Published on May 7th, 2022

The new multi-organ chip has the size of a glass microscope slide and allows the culture of up to four human engineered tissues, whose location and number can be tailored to the question being asked. These tissues are connected by vascular flow, but the presence of a selectively permeable endothelial barrier maintains their tissue-specific niche. Credit: Kacey Ronaldson-Bouchard/Columbia Engineering Major advance from Columbia Engineering team demonstrates the first multi-organ chip made of engineered human tissues linked by vascular flow for improved modeling of systemic diseases like cancer Continue reading

Posted in Vascular Biology | Comments Off on Plug-and-Play Human Organ-on-a-Chip Can Be Customized to the Patient – SciTechDaily

The Hunt for Protein Culprits in COVID-19’s Cardiac Complications – TCTMD

Posted: Published on May 7th, 2022

For 2 years, physicians and scientists have puzzled over the cardiovascular complications from COVID-19, but new proteomics research is helping to shed light on some of the biological mechanisms driving this heightened risk. Continue reading

Posted in Vascular Biology | Comments Off on The Hunt for Protein Culprits in COVID-19’s Cardiac Complications – TCTMD

Worsening Cardiovascular Risk Profile Linked to Cognitive… : Neurology Today – LWW Journals

Posted: Published on May 7th, 2022

By Dan Hurley May 5, 2022 The Science Explained Article In Brief Researchers tracked the link between cardiovascular disease (CVD) and dementia for approximately 25 years, finding that individuals whose CVD risk factors increase sharply over a period of years and decades are more than three times more likely to develop Alzheimer's disease or vascular dementia than are people whose CVD risk remains relatively steady. Our experts said the results demonstrate the need to pay greater attention to patients' CVD risk factors Continue reading

Posted in Vascular Biology | Comments Off on Worsening Cardiovascular Risk Profile Linked to Cognitive… : Neurology Today – LWW Journals

Breaking Through to the Brain – University of California San Diego

Posted: Published on May 7th, 2022

Ester Kwon, a professor of bioengineering at the Jacobs School of Engineering, is developing nanomaterials to diagnose and treat traumatic brain injuries. Photos by Erik Jepsen/UC San Diego Traumatic brain injuries might have faded from the headlines since the NFL reached a $765 million settlement for concussion-related brain injuries, but professional football players arent the only ones impacted by these injuries. Continue reading

Posted in Vascular Biology | Comments Off on Breaking Through to the Brain – University of California San Diego

Page 258«..1020..257258259260..270280..»